FOGHORN THERAPEUTICS INC's ticker is FHTX and the CUSIP is 344174107. A total of 61 filers reported holding FOGHORN THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,130,671 | -25.6% | 426,082 | +4.8% | 0.00% | – |
Q2 2023 | $2,862,097 | +19.6% | 406,548 | +5.3% | 0.00% | – |
Q1 2023 | $2,393,249 | +101223.0% | 386,008 | +4.3% | 0.00% | – |
Q4 2022 | $2,362 | -99.9% | 370,249 | +0.4% | 0.00% | – |
Q3 2022 | $3,162,000 | -34.8% | 368,627 | +3.4% | 0.00% | -100.0% |
Q2 2022 | $4,848,000 | -9.1% | 356,507 | +1.8% | 0.00% | 0.0% |
Q1 2022 | $5,333,000 | -32.9% | 350,184 | +0.8% | 0.00% | 0.0% |
Q4 2021 | $7,944,000 | +109.2% | 347,395 | +27.4% | 0.00% | 0.0% |
Q3 2021 | $3,798,000 | +49.8% | 272,707 | +14.7% | 0.00% | – |
Q2 2021 | $2,536,000 | +31.3% | 237,744 | +62.1% | 0.00% | – |
Q1 2021 | $1,932,000 | -28.1% | 146,640 | +10.7% | 0.00% | – |
Q4 2020 | $2,686,000 | – | 132,512 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Euclidean Capital LLC | 1,261,261 | $17,153,000 | 14.59% |
Flagship Pioneering Inc. | 12,674,120 | $172,368,000 | 6.49% |
Birchview Capital, LP | 284,843 | $3,874,000 | 2.82% |
Artal Group S.A. | 1,720,720 | $23,402,000 | 1.25% |
Alphabet Inc. | 500,901 | $6,812,000 | 0.37% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 777,525 | $10,574,000 | 0.22% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 382,940 | $5,208,000 | 0.08% |
XTX Topco Ltd | 11,436 | $156,000 | 0.06% |
Virtus ETF Advisers LLC | 8,198 | $111,000 | 0.04% |
Dynamic Technology Lab Private Ltd | 20,551 | $279,000 | 0.03% |